1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Neurovascular Devices/Interventional Neurology Market by Product, Pathology - Global Forecasts to 2021

Neurovascular Devices/Interventional Neurology Market: Global Forecasts until 2021

  • March 2017
  • 195 pages
  • ID: 4759533
In this report:
In terms of volume, the aneurysm coiling & embolization devices segment is expected to account for the largest share of ##.##% of the global neurovascular devices/interventional neurology product market, by product, in 2016 and is projected to grow at a CAGR of ##.##% from ##,##,## units in 2016 to ##,##,## units by 2021.

Summary

Table of Contents

Search Inside

The overall neurovascular devices/interventional neurology market is estimated reach ~$2.6M at a Compound annual growth rate of 8.60 percent during 2016-2021. As of 2016, North America (NA) and EU maintains the biggest share of the market; on the other hand, the Asia Pacific (APAC) area is poised to be the fastest growing area during next five years owing to Elements such as the presence of a big patient population base for target diseases, growing awareness among neurosurgeons associated to the benefits suggested by interventional neurology devices, ongoing government initiatives to modernize & expand healthcare infrastructure, and growing adoption of neurovascular devices due to decreasing product price (owing to increasingly localized manufacturing and strengthening of distribution networks).

Industry growth in the industry is mainly influenced by Elements such as considerable target patient population base, ongoing product improvement & commercialization, favorable medical reimbursements, expansion of healthcare infrastructure across emerging industries and increasing market demand for effective neurovascular devices. The Elements such as the rising number of research activities in the field of neurovascular therapies and increasing demand for minimally invasive neurosurgical procedures are anticipated to offer renewed increase opportunities for the key market players during the outlook period.

Geographically, North America continent is forecasted to command the biggest share of the overall market in 2016, succeeded by Europe (EU). The significant market share of the North American area can be accredited to growing adoption of neurovascular devices among neurosurgeons in neurovascular disease treatment, the increasing number of clinical trials, significant medical reimbursement available in the U.S. for neurosurgical procedures, important patient population for target diseases, favorable reimbursement scenario, strong presence of device manufacturers in the area, and availability of significant R&D investments to support neurovascular product improvement. Nevertheless, industry growth will be negatively affected due to the unfavorable regulatory scenario in the territory, which may result in increased pricing pressure on main neurovascular device manufacturers.

The sector is highly competitive, with a big number of overall and local manufacturers of neurovascular products. Stryker Corporation, Medtronic Plc, and Johnson & Johnson were the most important three market actors in the industry, in 2015.

Report Objective:

This report studies neurovascular devices/interventional neurology market established on products, disease pathology, and area.

The report also studies, the factors (including drivers, industry restraints, alternatives, and opportunities) which affect the market increase in a positive and negative manner. It examines possibilities and opportunities in the sector for partners and offers details of the competitive landscape for industry top players. Moreover, the neurovascular devices/interventional neurology market report examines the micromarkets with respect to their individual progress trends, prospects, and contributions to the neurovascular devices/interventional neurology market.

Why acquiring this study can help you:

From an insights perspective, this market research is mostly focused on several levels of analysis-industry trends, market share review of top ten actors, and company descriptions, which together discuss basic views on the competitive landscape, coming out and high increase segments of the neurovascular devices/interventional neurology market, and high increase regions and their respective drivers, market restraints, and alternatives.

The market research will increase both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate organizations in garnering greater market shares. Companies obtaining the industry report could use any one or an aggregation of the below-mentioned five strategies for strengthening their market shares.

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on product types provided by the main players in the neurovascular devices/interventional neurology market. The analysis examines the industry established on product, disease pathology, and area.

• Product Development/Innovative products: In-depth understanding on the next technologies, analysis and growth activities, and launches of new product in the neurovascular devices/interventional neurology market

• Market Development: Highlighted information about profitable emerging sectors. The market research examines the sector for different neurovascular devices/interventional neurology products across geographies

• industry diversification: Complete information about recent products, untapped areas, recent evolutions, and market investments in the neurovascular devices/interventional neurology market

• opposing assessment: Detailed assessment of market shares, strategies, products, distribution networks, and manufacturing competences of key players in the neurovascular devices/interventional neurology market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Hemiplegia Global Clinical Trials Review, H2, 2017

Clinical Research in Hemiplegia in H2, 2017

  • $ 2500
  • Industry report
  • September 2017
  • by GlobalData

Hemiplegia Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Hemiplegia Global Clinical Trials Review, H2, 2017" provides an overview of Hemiplegia clinical trials ...

Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2017

Clinical Research in Hypoxic-Ischemic Encephalopathy in H2, 2017

  • $ 2500
  • Industry report
  • October 2017
  • by GlobalData

Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2017" provides ...

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2017

Clinical Research in Intracerebral Hemorrhage in H2, 2017

  • $ 2500
  • Industry report
  • October 2017
  • by GlobalData

Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2017" provides an overview of ...

Multiple Sclerosis [2017] $ 8355 November 2017


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.